Monday, June 17, 2024
|
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
17.06.2024 / 10:05 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
| Name: |
SCHOTT Pharma AG & Co. KGaA |
| Street: |
Hattenbergstraße 10 |
| Postal code: |
55122 |
| City: |
Mainz
Germany |
| Legal Entity Identifier (LEI): |
529900TU48UE99NHEY88 |
2. Reason for notification
| X |
Acquisition/disposal of shares with voting rights |
| X |
Acquisition/disposal of instruments |
| |
Change of breakdown of voting rights |
| |
Other reason:
|
3. Details of person subject to the notification obligation
Legal entity: T. Rowe Price Group, Inc.
City of registered office, country: Baltimore, Maryland, United States of America (USA) |
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached:
6. Total positions
| |
% of voting rights attached to shares
(total of 7.a.) |
% of voting rights through instruments
(total of 7.b.1 + 7.b.2) |
Total of both in %
(7.a. + 7.b.) |
Total number of voting rights pursuant to Sec. 41 WpHG |
| New |
3.01 % |
0.05 % |
3.06 % |
150614616 |
| Previous notification |
n/a % |
n/a % |
n/a % |
/ |
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
| ISIN |
Absolute |
In % |
| |
Direct
(Sec. 33 WpHG) |
Indirect
(Sec. 34 WpHG) |
Direct
(Sec. 33 WpHG) |
Indirect
(Sec. 34 WpHG) |
| DE000A3ENQ51 |
0 |
4536896 |
0.00 % |
3.01 % |
| Total |
4536896 |
3.01 % |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Voting rights absolute |
Voting rights in % |
| shares on loan |
|
|
70238 |
0.05 % |
| |
|
Total |
70238 |
0.05 % |
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Cash or physical settlement |
Voting rights absolute |
Voting rights in % |
|
|
|
|
0 |
0.00 % |
| |
|
|
Total |
0 |
0.00 % |
8. Information in relation to the person subject to the notification obligation| |
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). |
| X |
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name |
% of voting rights (if at least 3% or more) |
% of voting rights through instruments (if at least 5% or more) |
Total of both (if at least 5% or more) |
| T. Rowe Price Group, Inc. |
% |
% |
% |
| T. Rowe Price Associates, Inc. |
% |
% |
% |
| T. Rowe Price International Ltd |
% |
% |
% |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting: | Proportion of voting rights |
Proportion of instruments |
Total of both |
| % |
% |
% |
10. Other explanatory remarks:
Date
17.06.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
SCHOTT Pharma AG & Co. KGaA |
|
Hattenbergstraße 10 |
|
55122 Mainz |
|
Germany |
| |
| End of News |
EQS News Service |
1926557 17.06.2024 CET/CEST
